Trinity College Dublin news release
In a new study published in the journal Frontiers in Immunology, researchers assessed the impact of PrEP on how immune cells function and use energy.
To explore these effects, researchers analysed blood samples before and after treatment began, and assessed changes in immune cell activity linked to PrEP use. The team also studied immune cells from people who had been taking PrEP for more than a year.
The study focused on monocytes, a type of immune cell that acts as one of the body’s first responders to infection. Researchers found clear differences between the monocytes of people taking PrEP and those of people who were not.
The findings offer new insight into how PrEP might affect the immune system beyond its role in preventing HIV, helping build a better understanding of inflammation and immune regulation, both in people living with HIV and in those taking PrEP.
Read the full news release here.
Source : Trinity College Dublin
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.